Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats

Details for Australian Patent Application No. 2007353147 (hide)

Owner Universidad Nacional Autonoma De Mexico

Inventors Gurrola-Briones, Georgina; Gaspar, Rezso; Possani Postay, Lourival Domingos; Varga, Zoltan S.; SalasCastillo, Saida Patricia; Panyi, Gyorgy; Ferreira Batista, Cesar Vicente

Agent Chrysiliou Law

Pub. Number AU-A-2007353147

PCT Pub. Number WO2008/139243

Filing date 14 May 2007

Wipo publication date 20 November 2008

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/139243 Priority application(s): WO2008/139243

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007353164-Cement mortar panel with pretensed biaxial reinforcement

2007353145-Uses of north american ginseng fractions for treating leukemia